| Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies E Stockings, G Campbell, WD Hall, S Nielsen, D Zagic, R Rahman, ... Pain 159 (10), 1932-1954, 2018 | 444 | 2018 |
| Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis S Nielsen, P Sabioni, JM Trigo, MA Ware, BD Betz-Stablein, B Murnion, ... Neuropsychopharmacology 42 (9), 1752-1765, 2017 | 278 | 2017 |
| Management of benzodiazepine misuse and dependence J Brett, B Murnion Australian prescriber 38 (5), 152, 2015 | 275 | 2015 |
| The assessment of frailty in older people in acute care SN Hilmer, V Perera, S Mitchell, BP Murnion, J Dent, B Bajorek, ... Australasian journal on ageing 28 (4), 182-188, 2009 | 261 | 2009 |
| Neuropathic pain: current definition and review of drug treatment BP Murnion Australian prescriber 41 (3), 60, 2018 | 181 | 2018 |
| Examination of opioid prescribing in Australia from 1992 to 2007 M Leong, B Murnion, PS Haber Internal medicine journal 39 (10), 676-681, 2009 | 167 | 2009 |
| Management of injecting drug users admitted to hospital PS Haber, A Demirkol, K Lange, B Murnion The Lancet 374 (9697), 1284-1293, 2009 | 153 | 2009 |
| Prescription and administration of opioids to hospital in-patients, and barriers to effective use BP Murnion, D Gnjidic, SN Hilmer Pain Medicine 11 (1), 58-66, 2010 | 80 | 2010 |
| Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial CMP Jones, RO Day, BW Koes, J Latimer, CG Maher, AJ McLachlan, ... The Lancet 402 (10398), 304-312, 2023 | 76 | 2023 |
| Medicinal cannabis B Murnion Australian prescriber 38 (6), 2015 | 64 | 2015 |
| Hepatotoxicity of therapeutic short‐course paracetamol in hospital inpatients: impact of ageing and frailty SJ Mitchell, SN Hilmer, BP Murnion, S Matthews Journal of Clinical Pharmacy and Therapeutics 36 (3), 327-335, 2011 | 60 | 2011 |
| Excitation and inhibition of rat medial vestibular nucleus neurones by 5-hydroxytryptamine AR Johnston, B Murnion, DS McQueen, MB Dutia Experimental brain research 93, 293-298, 1993 | 54 | 1993 |
| Perceived stigma and social support in treatment for pharmaceutical opioid dependence S Cooper, G Campbell, B Larance, B Murnion, S Nielsen Drug and alcohol review 37 (2), 262-272, 2018 | 53 | 2018 |
| Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies S Nielsen, L Picco, B Murnion, B Winters, J Matheson, M Graham, ... Neuropsychopharmacology 47 (7), 1315-1330, 2022 | 51 | 2022 |
| General practitioners' diagnostic skills and referral practices in managing patients with drug and alcohol‐related health problems: implications for medical training and … USAM FUCITO, BS Gomes, B Murnion, PS Haber Drug and alcohol review 22 (4), 417-424, 2003 | 48 | 2003 |
| Cannabinoids for the treatment of spasticity S Nielsen, B Murnion, G Campbell, H Young, W Hall Developmental Medicine & Child Neurology 61 (6), 631-638, 2019 | 40 | 2019 |
| Combination analgesics in adults BP Murnion Aust Prescr 33 (4), 113-5, 2010 | 39 | 2010 |
| Comparing treatment‐seeking codeine users and strong opioid users: findings from a novel case series S Nielsen, B Murnion, A Dunlop, L Degenhardt, A Demirkol, P Muhleisen, ... Drug and Alcohol Review 34 (3), 304-311, 2015 | 36 | 2015 |
| Current insights on the impact of gamma-hydroxybutyrate (GHB) abuse E Tay, WKW Lo, B Murnion Substance Abuse and Rehabilitation, 13-23, 2022 | 26 | 2022 |
| Routine opioid outcome monitoring in community pharmacy: pilot implementation study protocol S Nielsen, M Kowalski, P Wood, S Larney, R Bruno, M Shanahan, ... Research in Social and Administrative Pharmacy 15 (8), 1047-1055, 2019 | 25 | 2019 |
